CEPI Calls for Proposals

CEPI issues continuous Open Calls for Proposals targeting vaccine candidates and biologic countermeasures against its priority pathogen list: Chikungunya, Coronaviruses, Disease X, Filoviruses (Ebola/Marburg), Lassa fever, Mpox, Nipah, and Rift Valley fever. Eligibility is global — academic institutions, biotech companies, and vaccine manufacturers with relevant R&D or manufacturing capacity are all eligible. Awards are milestone-based and carry equitable-access conditions requiring recipients to make resulting vaccines available at affordable prices in outbreak settings. CEPI's approach combines financial investment with systems-level partnership (470+ R&D partners across 75+ vaccine candidates). Awards above $100M require Investor Council approval. The foundation uses vaccine bonds via the International Finance Facility for Immunisation (IFFIm) to frontload pledged capital and accelerate vaccine development timelines.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.